Featured Research

from universities, journals, and other organizations

Making Emergency Artery Repair Safer

Date:
January 2, 2008
Source:
Blackwell Publishing Ltd.
Summary:
Catheters outfitted with balloons, lasers, and miniature drills have made the treatment of blocked arteries virtually routine. These devices are used to clear plaque from many vessels including coronary, femoral, renal, and carotid arteries.

Catheters outfitted with balloons, lasers, and miniature drills have made the treatment of blocked arteries virtually routine. These devices are used to clear plaque from many vessels including coronary, femoral, renal, and carotid arteries. Until recently, a misstep in the delicate procedure usually required risky emergency surgery.

Now physicians are using the same technology used to open clogged arteries to repair ruptures and perforations with less risk. In an article in the Journal of Interventional Cardiology, researchers from the University of California, Davis Medical Center review state-of-the-art treatment for vessel punctures.

“Rupture or perforation of a blood vessel during angioplasty can result in life-threatening bleeding,” said lead author John Laird, M.D. “This review provides doctors with a summary of equipment and techniques that will enhance their ability to treat such complications.”

An estimated 0.1% of patients undergoing balloon angioplasty, which uses an inflatable balloon to widen arteries, suffer a perforation during the procedure. Patients treated with a rotablator drill have a 1.3% risk of perforation, while those treated with the excimer laser face a 1.9% risk. Balloon, drill, and laser are all attached to a catheter inserted through a small incision in the arm or groin and snaked through an artery to the blockage.

Following a puncture, Laird and his colleagues first recommend inflating a balloon at the site to stem the bleeding. Then they suggest inserting embolization coils or a flexible tube called a stent graft to repair the vessel. Treatment also involves drug therapy to promote clotting.

In their review, the authors describe several types of balloons, stents, and coils. They urge physicians who perform angioplasty to become familiar with the supplies they stock in order to be prepared for an emergency.


Story Source:

The above story is based on materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "Making Emergency Artery Repair Safer." ScienceDaily. ScienceDaily, 2 January 2008. <www.sciencedaily.com/releases/2007/12/071206110813.htm>.
Blackwell Publishing Ltd.. (2008, January 2). Making Emergency Artery Repair Safer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/12/071206110813.htm
Blackwell Publishing Ltd.. "Making Emergency Artery Repair Safer." ScienceDaily. www.sciencedaily.com/releases/2007/12/071206110813.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins